Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis
ObjectiveTo investigate the features of gut microbiota in cirrhotic patients with myosteatosis and identify specific bacterial species that may be involved in the pathogenesis of myosteatosis.Methods80 patients with liver cirrhosis were categorized into the myosteatosis group (n = 44) and the non-my...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1513973/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832542355472777216 |
|---|---|
| author | Ninghui Zhao Jinjia Bai Xinmiao Li Guofen Xu Xiujuan Fu Jing Li Lingyun Niu Jia Yao Xiaoshuang Zhou |
| author_facet | Ninghui Zhao Jinjia Bai Xinmiao Li Guofen Xu Xiujuan Fu Jing Li Lingyun Niu Jia Yao Xiaoshuang Zhou |
| author_sort | Ninghui Zhao |
| collection | DOAJ |
| description | ObjectiveTo investigate the features of gut microbiota in cirrhotic patients with myosteatosis and identify specific bacterial species that may be involved in the pathogenesis of myosteatosis.Methods80 patients with liver cirrhosis were categorized into the myosteatosis group (n = 44) and the non-myosteatosis group (n = 36). Metagenomic sequencing was used to analyze the differences in gut microbiota composition between the two groups. Subsequently, the value of meaningful gut microbiota in the diagnosis of myosteatosis in patients with liver cirrhosis was analyzed.ResultsAt the species level, however, 15 bacterial species exhibited significant differences in relative abundance between these two groups. The relative abundance of Roseburia hominis and Subdoligranulum unclassified was inversely associated with mean muscle attenuation density at the L3 level (p < 0.05). Assessement of the diagnostic potential of Roseburia hominis and Subdoligranulum unclassified for the development of myosteatosis showed that the areas under the ROC curves (AUCs) was 0.869 [95% confidence interval (CI): 0.709–1.029; p < 0.05] for Roseburia hominis and 0.828 (95% CI: 0.6472–1.009; p < 0.05) for Subdoligranulum unclassified.ConclusionOur study establishes compositional alterations of gut microbiota in patients with liver cirrhosis combined with myosteatosis and suggests the diagnostic potential for using gut microbiota as noninvasive biomarkers. |
| format | Article |
| id | doaj-art-13c3c17107ca4db2af9613292f824f1d |
| institution | Kabale University |
| issn | 2296-861X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Nutrition |
| spelling | doaj-art-13c3c17107ca4db2af9613292f824f1d2025-02-04T05:28:05ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-02-011210.3389/fnut.2025.15139731513973Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosisNinghui Zhao0Jinjia Bai1Xinmiao Li2Guofen Xu3Xiujuan Fu4Jing Li5Lingyun Niu6Jia Yao7Xiaoshuang Zhou8Department of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, ChinaDepartment of Nephrology, The Affiliated People’s Hospital of Shanxi Medical University, Taiyuan, ChinaObjectiveTo investigate the features of gut microbiota in cirrhotic patients with myosteatosis and identify specific bacterial species that may be involved in the pathogenesis of myosteatosis.Methods80 patients with liver cirrhosis were categorized into the myosteatosis group (n = 44) and the non-myosteatosis group (n = 36). Metagenomic sequencing was used to analyze the differences in gut microbiota composition between the two groups. Subsequently, the value of meaningful gut microbiota in the diagnosis of myosteatosis in patients with liver cirrhosis was analyzed.ResultsAt the species level, however, 15 bacterial species exhibited significant differences in relative abundance between these two groups. The relative abundance of Roseburia hominis and Subdoligranulum unclassified was inversely associated with mean muscle attenuation density at the L3 level (p < 0.05). Assessement of the diagnostic potential of Roseburia hominis and Subdoligranulum unclassified for the development of myosteatosis showed that the areas under the ROC curves (AUCs) was 0.869 [95% confidence interval (CI): 0.709–1.029; p < 0.05] for Roseburia hominis and 0.828 (95% CI: 0.6472–1.009; p < 0.05) for Subdoligranulum unclassified.ConclusionOur study establishes compositional alterations of gut microbiota in patients with liver cirrhosis combined with myosteatosis and suggests the diagnostic potential for using gut microbiota as noninvasive biomarkers.https://www.frontiersin.org/articles/10.3389/fnut.2025.1513973/fullliver cirrhosismyosteatosisgut microbiotametagenomic sequencingdiagnostic value |
| spellingShingle | Ninghui Zhao Jinjia Bai Xinmiao Li Guofen Xu Xiujuan Fu Jing Li Lingyun Niu Jia Yao Xiaoshuang Zhou Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis Frontiers in Nutrition liver cirrhosis myosteatosis gut microbiota metagenomic sequencing diagnostic value |
| title | Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis |
| title_full | Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis |
| title_fullStr | Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis |
| title_full_unstemmed | Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis |
| title_short | Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis |
| title_sort | correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis |
| topic | liver cirrhosis myosteatosis gut microbiota metagenomic sequencing diagnostic value |
| url | https://www.frontiersin.org/articles/10.3389/fnut.2025.1513973/full |
| work_keys_str_mv | AT ninghuizhao correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT jinjiabai correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT xinmiaoli correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT guofenxu correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT xiujuanfu correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT jingli correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT lingyunniu correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT jiayao correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis AT xiaoshuangzhou correlationstudyongutmicrobiotaandmyosteatosisinpatientswithlivercirrhosis |